Stocks › BMA
Banco Macro BMA
US equityMarket cap rank #2388
$49.86 −$1.66 (-3.22%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $50.50 +1.28%
Open$49.50
Prev close$51.52
Day range$49.50 – $52.10
Volume361.1K
Market cap$3.19B
P/E (TTM)13.0
Dividend yield10.12%
Fundamentals
Latest reported quarter: Q2, ended Jun 2026 · reported in ARS
RevenueARS 1.04T-20.6% YoY
Net profitARS 206.78B+3.5% YoY
Diluted EPSARS 3,224.84+3.5% YoY
Free cash flow-ARS 409.85B+40.2% YoY
Operating cash flow-ARS 371.68B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Net margin9.5%
Return on equity7.1%
Return on assets1.7%
Liabilities / assets75.6%
Cash & investmentsARS 4.49T
Total debtARS 1.64T
Net cash (debt)ARS 2.85T
Free cash flow / sales46.5%
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Income statement
| Line item | 2026 Q2 (ARS) |
2026 Q1 (ARS) |
2025 ANNUAL (ARS) |
2025 Q4 (ARS) |
2025 Q3 (ARS) |
|---|---|---|---|---|---|
| Total Operating Revenue | ARS 1.04T | ARS 1.40T | ARS 4.38T | ARS 1.50T | ARS 870.50B |
| Net Interest Income | ARS 730.80B | ARS 979.05B | ARS 3.07T | ARS 994.03B | ARS 677.85B |
| -Interest Income | ARS 1.15T | ARS 1.48T | ARS 5.04T | ARS 1.68T | ARS 1.22T |
| -Interest Expense | ARS 422.81B | ARS 502.59B | ARS 1.97T | ARS 684.18B | ARS 547.15B |
| Non-Interest Income | ARS 308.79B | ARS 425.49B | ARS 1.31T | ARS 504.70B | ARS 192.66B |
| -Fees and Commissions | ARS 323.01B | ARS 202.69B | ARS 761.93B | ARS 234.03B | ARS 168.98B |
| -Foreign Exchange Trading Gains | ARS 22.12B | ARS 61.11B | ARS 25.10B | ARS 7.93B | -ARS 13.79B |
| -Other Non-Interest Income | ARS 22.70B | ARS 7.39B | ARS 64.65B | ARS 20.90B | ARS 17.99B |
| -Gain Loss on Sale of Assets | -ARS 59.03B | ARS 154.29B | ARS 456.33B | ARS 241.84B | ARS 19.47B |
| Non-Interest Expense | ARS 258.60B | ARS 596.22B | ARS 2.27T | ARS 765.59B | ARS 546.94B |
| Selling and Admin Expenses | ARS 356.70B | ARS 348.76B | ARS 1.40T | ARS 508.99B | ARS 323.13B |
| -Selling & Marketing Expense | ARS 12.63B | ARS 13.54B | ARS 52.60B | ARS 30.36B | ARS 8.87B |
| -General & Admin Expense | ARS 344.08B | ARS 335.22B | ARS 1.35T | ARS 478.63B | ARS 314.26B |
| Depreciation & Amortization & Depletion | ARS 49.58B | ARS 46.66B | ARS 178.82B | ARS 53.84B | ARS 41.79B |
| -Depreciation & Amortization | ARS 49.58B | ARS 46.66B | ARS 178.82B | ARS 53.84B | ARS 41.79B |
| Other Non-Interest Expenses | -ARS 147.68B | ARS 200.80B | ARS 695.45B | ARS 202.76B | ARS 182.02B |
| Other Income (Expense) | -ARS 278.86B | -ARS 357.53B | -ARS 1.06T | -ARS 337.80B | -ARS 202.95B |
| Income from Associates & Other Participating Interests | -ARS 7.47B | -ARS 7.30B | -ARS 257.03M | -ARS 817.63M | ARS 681.43M |
| Special Income (Charges) | -ARS 271.39B | -ARS 350.23B | -ARS 1.06T | -ARS 336.98B | -ARS 203.63B |
| -Less:Other Special Charges | ARS 271.39B | ARS 350.23B | ARS 1.06T | ARS 336.98B | ARS 203.63B |
| Pretax Profit | ARS 324.92B | ARS 212.69B | ARS 511.12B | ARS 199.14B | -ARS 38.03B |
| Tax | -ARS 118.15B | ARS 72.93B | ARS 220.42B | ARS 85.18B | -ARS 4.96B |
| Net Profit | ARS 206.78B | ARS 139.76B | ARS 290.71B | ARS 113.97B | -ARS 33.07B |
| Profit from Continuing Operations | ARS 206.78B | ARS 139.76B | ARS 290.71B | ARS 113.97B | -ARS 33.07B |
| Minority Interests | -ARS 582.13M | -ARS 480.92M | ARS 1.21B | -ARS 203.05M | ARS 31.55M |
| Net Income to Parent Company | ARS 206.19B | ARS 140.24B | ARS 289.49B | ARS 114.17B | -ARS 33.10B |
| Net Income to Common Stockholders | ARS 206.19B | ARS 140.24B | ARS 289.49B | ARS 114.17B | -ARS 33.10B |
| Basic EPS | ARS 3,224.84 | ARS 2,193.32 | ARS 4,527.54 | ARS 1,785.57 | -ARS 517.61 |
| Diluted EPS | ARS 3,224.84 | ARS 2,193.32 | ARS 4,527.54 | ARS 1,785.57 | -ARS 517.61 |
| Dividend Per Share | ARS 2,905.29 | ARS 1,606.27 | ARS 2,974.74 | ARS 1,463.79 | ARS 984.89 |
| Credit Losses Provision | – | -ARS 238.81B | -ARS 538.14B | -ARS 196.21B | -ARS 158.64B |
Balance sheet
| Line item | 2026 Q2 (ARS) |
2026 Q1 (ARS) |
2025 ANNUAL (ARS) |
2025 Q4 (ARS) |
2025 Q3 (ARS) |
|---|---|---|---|---|---|
| Total Assets | ARS 25.76T | ARS 24.20T | ARS 23.24T | ARS 23.24T | ARS 20.56T |
| Cash, Cash Equivalents & Federal Funds Sold | ARS 4.62T | ARS 4.83T | ARS 4.69T | ARS 4.69T | ARS 3.37T |
| -Cash and Cash Equivalents | ARS 4.49T | ARS 4.73T | ARS 4.51T | ARS 4.51T | ARS 3.37T |
| -Money Market Investments | ARS 134.39B | ARS 101.73B | ARS 181.15B | ARS 181.15B | – |
| Securities Investment | ARS 7.58T | ARS 6.31T | ARS 5.66T | ARS 5.66T | ARS 4.76T |
| -Available for Sale Securities | ARS 7.46T | ARS 6.20T | ARS 5.54T | ARS 5.54T | ARS 4.65T |
| -Short Term Investments | ARS 121.53B | ARS 117.35B | ARS 118.17B | ARS 118.17B | ARS 113.39B |
| Long Term Equity Investment | ARS 114.08B | ARS 113.26B | ARS 6.17B | ARS 6.17B | ARS 5.25B |
| Derivative Assets | ARS 282.57M | ARS 8.00B | ARS 7.95B | ARS 7.95B | ARS 305.32B |
| Net Loan | ARS 11.68T | ARS 10.62T | ARS 9.97T | ARS 9.97T | ARS 10.11T |
| -Gross Loan | ARS 12.40T | ARS 11.27T | ARS 10.54T | ARS 10.54T | ARS 10.51T |
| -Allowance for Loans and Lease Losses | ARS 720.14B | ARS 652.34B | ARS 507.53B | ARS 507.53B | ARS 400.11B |
| Receivables | ARS 11.02B | ARS 581.88B | ARS 1.42T | ARS 1.42T | ARS 638.73B |
| -Other Receivables | ARS 11.02B | ARS 181.14B | ARS 166.16B | ARS 166.16B | ARS 346.91B |
| Net PPE | ARS 1.19T | ARS 1.12T | ARS 1.04T | ARS 1.04T | ARS 966.04B |
| -Gross PPE | ARS 1.75T | ARS 1.62T | ARS 1.48T | ARS 1.48T | ARS 1.36T |
| -Accumulated Depreciation | -ARS 556.47B | -ARS 501.26B | -ARS 441.54B | -ARS 441.54B | -ARS 392.72B |
| Goodwill and Other Intangible Assets | ARS 204.56B | ARS 194.48B | ARS 182.85B | ARS 182.85B | ARS 173.24B |
| -Other Intangible Assets | ARS 204.56B | ARS 194.48B | ARS 182.85B | ARS 182.85B | ARS 173.24B |
| Prepaid Assets | ARS 43.05B | ARS 66.87B | ARS 47.54B | ARS 47.54B | ARS 53.66B |
| Deferred Assets | ARS 83.71B | ARS 130.48B | ARS 23.10B | ARS 23.10B | ARS 1.11B |
| Assets Held for Sale | ARS 122.77B | ARS 112.21B | ARS 94.12B | ARS 94.12B | ARS 90.68B |
| Other Assets | ARS 111.68B | ARS 105.27B | ARS 99.84B | ARS 99.84B | ARS 89.83B |
| Total Liabilities | ARS 19.46T | ARS 18.34T | ARS 18.00T | ARS 18.00T | ARS 15.80T |
| Total Deposits | ARS 14.74T | ARS 13.99T | ARS 13.69T | ARS 13.69T | ARS 11.81T |
| Derivative Product Liabilities | ARS 298.64M | ARS 5.36B | ARS 498.73M | ARS 498.73M | ARS 3.14B |
| Trading Liabilities | ARS 19.55B | ARS 8.09B | ARS 14.72B | ARS 14.72B | ARS 12.46B |
| Payables | ARS 1.80T | ARS 2.21T | ARS 2.13T | ARS 2.13T | ARS 1.57T |
| -Total Tax Payable | ARS 513.23B | ARS 696.50B | ARS 537.75B | ARS 537.75B | ARS 209.53B |
| -Dividends Payable | ARS 49.23B | ARS 13.33M | ARS 115.13B | ARS 115.13B | ARS 215.19B |
| -Other Payable | ARS 1.24T | ARS 1.51T | ARS 1.48T | ARS 1.48T | ARS 1.15T |
| Current Accrued Expenses | ARS 82.72B | ARS 57.95B | ARS 59.51B | ARS 59.51B | ARS 168.87B |
| Long Term Debt and Capital Lease Obligation | ARS 1.64T | ARS 1.48T | ARS 1.36T | ARS 1.36T | ARS 1.31T |
| -Long Term Debt | ARS 1.62T | ARS 1.46T | ARS 1.35T | ARS 1.35T | ARS 1.29T |
| -Long Term Capital Lease Obligation | ARS 17.48B | ARS 15.89B | ARS 9.67B | ARS 9.67B | ARS 19.44B |
| Non-Current Liabilities | ARS 52.70B | ARS 65.11B | ARS 71.76B | ARS 71.76B | ARS 5.30B |
| Employee Benefits | ARS 124.28B | ARS 103.60B | ARS 133.36B | ARS 133.36B | ARS 4.58B |
| Non-Current Deferred Liabilities | ARS 2.00B | ARS 1.55B | ARS 1.18B | ARS 1.18B | ARS 209.35B |
| Other Liabilities | ARS 1.00T | ARS 423.06B | ARS 537.65B | ARS 537.65B | ARS 484.81B |
| Total Equity | ARS 6.29T | ARS 5.86T | ARS 5.23T | ARS 5.23T | ARS 4.76T |
| Stockholders' Equity | ARS 6.29T | ARS 5.86T | ARS 5.23T | ARS 5.23T | ARS 4.76T |
| Capital Stock | ARS 639.41M | ARS 639.41M | ARS 639.41M | ARS 639.41M | ARS 639.41M |
| -Common Stock | ARS 639.41M | ARS 639.41M | ARS 639.41M | ARS 639.41M | ARS 639.41M |
| Additional Paid-In Capital | ARS 12.43B | ARS 12.43B | ARS 12.43B | ARS 12.43B | ARS 12.43B |
| Retained Earnings | ARS 357.67B | ARS 458.10B | -ARS 808.98B | -ARS 808.98B | ARS 176.20B |
| Gains/Losses Not Affecting Retained Earnings | ARS 3.99T | ARS 3.58T | ARS 4.38T | ARS 4.38T | ARS 3.04T |
| Other Equity Interests | ARS 1.93T | ARS 1.81T | ARS 1.65T | ARS 1.65T | ARS 1.53T |
| Minority Interests | ARS 3.18B | ARS 2.83B | ARS 3.03B | ARS 3.03B | ARS 3.10B |
| -Accounts Receivable | – | ARS 400.75B | ARS 1.25T | ARS 1.25T | ARS 291.82B |
| -Unearned Income | – | – | -ARS 63.21B | -ARS 63.21B | – |
| Short-Term Debt and Capital Lease Obligation | – | – | ARS 9.47B | ARS 9.47B | – |
| -Current Capital Lease Obligation | – | – | ARS 9.47B | ARS 9.47B | – |
| Federal Funds Purchased and Securities Sold Under Agreement to Repurchase | – | – | – | – | ARS 207.58B |
| Current Provisions | – | – | – | – | ARS 24.23B |
Cash flow
| Line item | 2026 Q2 (ARS) |
2026 Q1 (ARS) |
2025 ANNUAL (ARS) |
2025 Q4 (ARS) |
2025 Q3 (ARS) |
|---|---|---|---|---|---|
| Operating Cash Flow | -ARS 371.68B | ARS 624.55B | ARS 555.20B | ARS 943.36B | ARS 818.90B |
| Net cash flow from continuing operations | -ARS 371.68B | ARS 624.55B | ARS 555.20B | ARS 943.36B | ARS 818.90B |
| Net Income from Continuing Operations | ARS 339.31B | ARS 212.69B | ARS 511.12B | ARS 199.14B | -ARS 129.12B |
| Gain/Loss from Continuing Operations | -ARS 144.17B | ARS 105.47B | -ARS 410.23B | -ARS 117.45B | -ARS 69.97B |
| Depreciation & Depletion & Amortization | ARS 52.74B | ARS 46.66B | ARS 178.82B | ARS 53.84B | ARS 20.13B |
| Other Non-Cash Items | ARS 79.64B | ARS 273.81B | ARS 859.66B | ARS 268.08B | ARS 21.89B |
| Change in Working Capital | -ARS 791.38B | -ARS 246.23B | -ARS 1.08T | ARS 355.05B | ARS 868.60B |
| -Change in Loans | -ARS 436.74B | ARS 946.07B | -ARS 3.82T | -ARS 615.65B | ARS 477.68B |
| -Change in Other Current Assets | -ARS 81.03B | ARS 56.91B | -ARS 6.05B | ARS 72.34B | -ARS 123.84B |
| -Change in Other Current Liabilities | ARS 201.00B | -ARS 300.84B | ARS 510.43B | ARS 315.31B | ARS 44.24B |
| -Change in Other Working Capital | -ARS 474.60B | -ARS 948.37B | ARS 2.24T | ARS 583.05B | ARS 470.51B |
| Net cash flow from investing | -ARS 38.18B | -ARS 30.57B | -ARS 171.95B | -ARS 52.75B | -ARS 20.37B |
| Net Cash Flow from Continuing Investing Activities | -ARS 38.18B | -ARS 30.57B | -ARS 171.95B | -ARS 52.75B | -ARS 20.37B |
| Net PPE Purchase and Sale | -ARS 38.18B | -ARS 30.57B | -ARS 171.95B | -ARS 52.75B | -ARS 20.37B |
| Financing Cash Flow | -ARS 129.54B | ARS 40.04B | ARS 534.11B | -ARS 8.24B | -ARS 20.56B |
| Net Cash Flow from Continuing Financing Activities | -ARS 129.54B | ARS 40.04B | ARS 534.11B | -ARS 8.24B | -ARS 20.56B |
| Net Issuance Payments of Debt | -ARS 63.82B | ARS 117.51B | ARS 705.16B | ARS 8.58B | ARS 81.06B |
| Cash Dividends Paid | -ARS 62.56B | -ARS 72.59B | -ARS 155.51B | -ARS 11.84B | -ARS 98.30B |
| Net Other Financing Activities | -ARS 3.16B | -ARS 4.89B | -ARS 15.36B | -ARS 4.81B | -ARS 3.32B |
| Ending Cash Balance | ARS 4.67T | ARS 4.96T | ARS 4.52T | ARS 4.52T | ARS 3.48T |
| Net Change in Cash | -ARS 539.40B | ARS 634.02B | ARS 917.36B | ARS 882.37B | ARS 777.98B |
| Beginning Cash Balance | ARS 4.96T | ARS 4.95T | ARS 3.77T | ARS 3.48T | ARS 3.48T |
| Effect of Exchange Rate Changes | ARS 251.77B | -ARS 193.94B | ARS 784.71B | ARS 239.04B | ARS 204.51B |
| Free Cash Flow | -ARS 409.85B | ARS 593.98B | ARS 383.25B | ARS 890.61B | ARS 798.53B |
| Net Common Stock Issuance | – | – | -ARS 180.98M | – | – |
No comments yet — be the first to weigh in on BMA.
Sign in to join the discussion.